Azienda Ospedaliera-Universitaria di Parma

Parma 43126

2 studies enrolling now · 6 studies all time

What they study most

Cholangiocarcinoma, Chronic Hepatitis B, IGF1 Deficiency, Idiopathic Parkinson's Disease, Non-Small Cell Lung Cancer, Peripheral T Cell Lymphoma

Studies at this site

• To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL — Recruiting now
• Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD). — Recruiting now
• Study of Tinengotinib VS. Physician's Choice a Treatment of Subjects With FGFR-altered in Cholangiocarcinoma — Running, not enrolling
• Long Term Follow-up Registry of Individuals Treated in A Gilead-Sponsored Trial in Individuals With Chronic Hepatitis B Infection — Stopped early
• A Study Comparing the Combination of the Best Supportive Care Plus E7080 Versus Best Supportive Care Alone, in Patients With Advanced Lung Cancer or Lung Cancer That Has Spread, Who Have Been Previously Treated, Unsuccessfully, With at Least 2 Different Treatments — Completed
• MOTION, Safinamide in Early IPD, as add-on to Dopamine Agonist — Completed